Abivax (ABVX) Interest & Investment Income (2024 - 2026)
Abivax (ABVX) recorded quarterly Interest & Investment Income of -$14.8 million in Q1 2026, up 32.94% quarter-over-quarter from -$22.1 million in Q3 2025, and down 1270.42% on a YoY basis from $1.3 million in Q1 2025.
Abivax (ABVX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Abivax's Interest & Investment Income history runs 3 years deep, the most recent figure standing at -$14.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 1270.42% year-over-year to -$14.8 million; the TTM figure through Mar 2026 stood at -$14.8 million (down 1270.42% YoY), while the FY2025 annual figure was $32.1 million, up 118.51% from the prior year.
- Interest & Investment Income was -$14.8 million for Q1 2026 at Abivax, up from -$22.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $10.9 million in Q3 2024 to a low of -$22.1 million in Q3 2025.
- Historically, Interest & Investment Income has averaged -$1.1 million across 3 years, with a median of $4.3 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income slumped 49.68% in 2025, then slumped 1270.42% in 2026.
- A 3-year view of Interest & Investment Income shows it stood at $10.9 million in 2024, then slumped by 301.86% to -$22.1 million in 2025, then surged by 32.94% to -$14.8 million in 2026.
- The last three Interest & Investment Income figures came in at -$14.8 million (Q1 2026), -$22.1 million (Q3 2025), and $4.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.79 Mn |
| Sep 30, 2025 | -22.06 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Sep 30, 2024 | 10.93 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 6.55 Mn |